Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Addict Med. 2017 Jan-Feb;11(1):19–27. doi: 10.1097/ADM.0000000000000262

Table 2. Methamphetamine use characteristics and severity of methamphetamine dependence and withdrawal compared between Thai male and female users by chi-square test.

Variables Total
(N=782)
Male
(N=413)
Female
(N=369)
χ2 df P-Value

n % n % n %

Age at first MA use onset (years)
≤15 213 27.2 120 29.1 93 25.2 27.8 2 <0.001**
16-18 298 38.1 184 44.6 114 30.9
>18 271 34.7 109 26.4 162 43.9

Age at MA dependence onset (years) (n=538)
< 20 261 48.5 139 56.5 122 41.8 11.6 1 0.001**
≥ 20 277 51.5 107 43.5 170 58.2

Duration of MA use (years) (n=781)
≤ 5 324 41.5 175 42.4 149 40.5 3.9 2 0.14
6-10 225 28.8 107 25.9 118 32.1
>10 232 29.7 131 31.7 101 27.4

Daily number of MA pills during the heaviest period of MA use
1-4 485 62.0 280 67.8 205 55.6 12.4 1 <0.001**
≥-5 297 38.0 133 33.2 164 44.4

Days per month of using MA during the heaviest period of MA use
≤ 15 280 35.8 163 39.5 117 31.7 5.1 1 0.02*
> 15 502 64.2 250 60.5 252 68.3

Number of episodes of MA use in lifetime (n=776)
≤ 1000 324 41.8 204 50.0 120 32.6 24.1 1 <0.001**
> 1000 452 58.2 204 50.0 248 67.4

MA dependence 537 68.7 246 59.6 291 78.9 33.7 1 <0.001**

Severity of MA dependence as measured by DSM-IV symptom count (n=536)
Non-severe (3-5) 224 41.8 115 46.9 109 37.5 4.9 1 0.03*
Severe (6-7) 312 58.2 130 53.1 182 62.5

Severity of MA withdrawal: number of withdrawal symptoms (n=642)
Mild (1-3) 191 29.8 101 31.1 90 28.5 0.5 2 0.78
Moderate (4-6) 370 57.6 184 56.4 186 58.9
Severe (7-9) 81 12.6 41 12.6 40 12.7

Route of MA use
Smoking 726 92.8 381 92.3 345 93.5 0.454 1 0.501
Orally 132 16.9 75 18.2 57 15.4 1.022 1 0.312
Snort 41 5.2 27 6.5 14 3.8 2.952 1 0.086
Injection 10 1.28 5 1.2 5 1.4 - - 1.000a
a

=Fisher's Exact Test

*

p < 0.05, chi-square test, two-tail

**

p < 0.01, chi-square test, two-tail